Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calceos
- Development stage
- Phase 3
- Lead developer
- Myralis
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Calceos is a pediatric-focused dietary supplement and over-the-counter (OTC) medication developed by the Brazilian pharmaceutical company Myralis. It is primarily available as an oral suspension, often marketed under the brand name Calceos Kids. The product is formulated with a combination of calcium and vitamin D3 (cholecalciferol) to support bone development, maintain mineral homeostasis, and prevent or treat nutritional deficiencies in children. As a product of Brazil's largest vitamin D manufacturer, Calceos is widely distributed in the Brazilian retail pharmacy market and is typically offered in child-friendly flavors such as cherry.
- Brand names
- CalceosCalceos Kids
- Other names
- Calceos Kids oral suspensionSuplemento alimentar em suspensão oral Calceos
02
Targets
VDR (Vitamin D receptor)
Beyond the preview
Go deeper on Calceos.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Calceos.